Financial Statements · Financial Reporting
TRIZLEX BIOPHARMA OÜ
Official identifier 11220756Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 28 Jun 2025
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 948,958 |
| Balance sheet | Cash and cash equivalents | 711,638 |
| Balance sheet | Current assets | 928,958 |
| Balance sheet | Current liabilities | 20,000 |
| Balance sheet | Equity | 892,258 |
| Balance sheet | Share capital at nominal value | 2,556 |
| Balance sheet | Non-current assets | 20,000 |
| Balance sheet | Non-current liabilities | 36,700 |
| Balance sheet | Retained earnings (loss) from previous periods | 470,895 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | 0 |
| Income statement scheme 1 | Labour costs | -52,612 |
| Income statement scheme 1 | Revenue | 987,018 |
| Income statement scheme 1 | Annual period profit / loss | 418,807 |
| Income statement scheme 1 | Operating profit (loss) | 418,807 |
| Income statement scheme 1 | Profit (loss) before income tax | 418,807 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 470,895 |
| Note: Labour costs | Employees | 2 |
| Note: Labour costs | Labour costs | 52,612 |
Linked company
Company: TRIZLEX BIOPHARMA OÜ